<!DOCTYPE html>
<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<title>input-fr</title>
</head>
<body><div id="lawcontent">
<div id="preface">
<h1 class="erlasstitel botschafttitel">Ordonnance du DEFR<br>sur le stockage obligatoire de médicaments</h1>
<p class="man-template-datum-aend">Modification du 13 novembre 2025</p>
</div>
<div id="preamble"><div>
<p class="man-template-autor man-space-before-10">Le Département fédéral de l’économie, de la formation et de la recherche (DEFR)</p>
<p class="man-template-verb man-space-before-3 man-space-after-18">arrête:</p>
</div></div>
<main id="maintext"><section id="lvl_I"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#lvl_I">I</a>
</h1>
<div class="collapseable">
<p class="absatz man-space-before-4">L’ordonnance du DEFR du 20 mai 2019 sur le stockage obligatoire de médicaments<sup><a href="#fn-d3351e22" id="fnbck-d3351e22">1</a></sup> est modifiée comme suit:</p>
<article class="man-art-mod" id="mod_u1"><a name=""></a><h6 class="heading man-mod-ref man-font-style-italic man-space-before-14" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#mod_u1">Art. 8, al. 1</a>
</h6>
<div class="collapseable"><p class="absatz man-space-before-4"><sup>1</sup> L’OFAE peut, après avoir consulté la société coopérative Helvecura (Helvecura), convenir avec les personnes astreintes au stockage et produisant leurs médicaments entièrement en Suisse qu’elles peuvent stocker ceux-ci sous la forme de principes actifs.</p></div></article><article class="man-art-mod" id="mod_u2"><a name=""></a><h6 class="heading man-mod-ref man-font-style-italic man-space-before-14" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#mod_u2">Art. 11, al. 1</a>
</h6>
<div class="collapseable"><p class="absatz man-space-before-4"><sup>1</sup> Les propriétaires peuvent procéder au transfert de tout ou partie de leurs réserves au titre du stockage obligatoire par délégation ou en commun.</p></div></article><div class="footnotes"><p id="fn-d3351e22"><sup><a href="#fnbck-d3351e22">1</a></sup><sup></sup> <a href="https://fedlex.data.admin.ch/vocabulary/legal-taxonomy/7699" target="_blank" data-rs-uri="https://fedlex.data.admin.ch/eli/cc/2019/351" data-rs="531.215.311" data-lang="fr">RS <b>531.215.311</b></a></p></div>
</div></section><section id="lvl_II"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#lvl_II">II</a>
</h1>
<div class="collapseable"><p class="absatz man-space-before-4">L’annexe 1 est modifiée conformément au texte ci-joint.</p></div></section><section id="lvl_III"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#lvl_III">III</a>
</h1>
<div class="collapseable">
<p class="absatz man-space-before-4">La présente ordonnance entre en vigueur le 15 janvier 2026.</p>
<p></p>
<div class="table layout-table"><table>
			
			
			<tr>
				
				<td>
					
					<p class="unterschriftenfi1 man-space-before-24">13 novembre 2025</p>
				</td>
				<td>
					
					<p class="unterschriftenfi1 man-space-before-24">Département fédéral de l’économie, <br>de la formation et de la recherche:</p>
					<p class="unterschriftenfi man-space-before-6">Guy Parmelin</p>
				</td>
			</tr>
		</table></div>
</div></section></main><div id="annex"><section id="annex_1"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1">Annexe 1</a>
</h1>
<div class="collapseable">
<p class="titelanhtext">(art. 1)</p>
<section id="annex_1/lvl_u1"><h2 class="heading" role="heading" aria-level="2">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1/lvl_u1">Marchandises visées à l’art. 1</a>
</h2>
<div class="collapseable">
<article class="man-art-mod" id="annex_1/lvl_u1/mod_u1"><a name=""></a><h6 class="heading man-mod-ref man-font-style-italic man-space-before-14" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1/lvl_u1/mod_u1">Ch. 4 et 5b</a>
</h6>
<div class="collapseable"></div></article><section id="annex_1/lvl_u1/lvl_4"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1/lvl_u1/lvl_4">4 Analgésiques à usage humain</a>
</h3>
<div class="collapseable">
<p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				
				<th class="man-text-align-left">
					
					<p class="man-template-tab-kpf man-space-before-3 man-space-after-3">Code ATC</p>
				</th>
				<th class="man-text-align-left">
					
					<p class="man-template-tab-kpf man-space-before-3 man-space-after-3">Désignation de la marchandise</p>
				</th>
				<th class="man-text-align-left">
					
					<p class="man-template-tab-kpf man-space-before-3 man-space-after-3">Remarque</p>
				</th>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-4">N01AH06</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-4">rémifentanil</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-4"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">N02AA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">morphine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">N02AA03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">hydromorphone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">N02AA05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">oxycodone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">N02AA55</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">association oxycodone-naloxone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">N02AB03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">fentanyl</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">N02AE01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">buprénorphine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">N02BA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">acide acétylsalicylique <br>y c. acétylsalicylate de lysine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">N07BC02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">méthadone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">N07BC05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">lévométhadone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr"></p>
				</td>
			</tr>
		</table></div>
</div></section><section id="annex_1/lvl_u1/lvl_5_b"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1/lvl_u1/lvl_5_b">5<span class="man-font-weight-normal"><i>b</i></span> Autres médicaments à usage humain</a>
</h3>
<div class="collapseable">
<p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				
				<th class="man-text-align-left">
					
					<p class="man-template-tab-kpf man-space-before-3 man-space-after-3">Code ATC</p>
				</th>
				<th class="man-text-align-left">
					
					<p class="man-template-tab-kpf man-space-before-3 man-space-after-3">Désignation de la marchandise</p>
				</th>
				<th class="man-text-align-left">
					
					<p class="man-template-tab-kpf man-space-before-3 man-space-after-3">Remarque</p>
				</th>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-4">B01AD02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-4">altéplase</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-4">dosage &gt; 2 mg</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">C01CA03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">noradrénaline</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">C01CA07</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">dobutamine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">C01CA24</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">adrénaline</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">auto-injecteurs</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">C03CA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">furosémide</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">C07AB02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">métoprolol</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">C07AG01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">labétalol</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">H01BB02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">ocytocine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">H02AB01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">bétaméthasone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">formes perorales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">H02AB09</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">hydrocortisone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">formes perorales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">M03AC09</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">bromure de rocuronium</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">N01AX10</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">propofol</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">N05BA06</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">lorazépam</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">V08BA</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">produits de contraste barytés</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">V08DA</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">produits de contraste pour échographie</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr"></p>
				</td>
			</tr>
		</table></div>
</div></section>
</div></section>
</div></section></div>
</div></body>
</html>
